Language

Global Opioid Use Disorder (OUD) In-Depth Monitoring and Development Analysis Report 2024

Length- 108 Pages | Published Date - 2023-12-02 | Report Id- 11031
Single Licence $3850.00 | Enterprise License $6200.00 | Multiple Licensee $6200.00
Description Table of Contents Table of Figures
The global Opioid Use Disorder (OUD) market size in 2023 is 3297.0 million US dollars, and it is expected to be 6384.1 million US dollars by 2030, with a compound annual growth rate of 9.9% expected in 2024-2030.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Opioid Use Disorder (OUD) market include Indivior PLC (Reckitt Benckiser Group plc), Collegium Pharmaceutical, Inc. (BioDelivery Sciences International, Inc.), Orexo AB (Orexo US, Inc.), Alkermes PLC, and Titan Pharmaceuticals, Inc.. The share of the top 3 players in the Opioid Use Disorder (OUD) market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Opioid Use Disorder (OUD) market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Buprenorphine accounted for XX% of Opioid Use Disorder (OUD) market in 2023. Methadone share of XX%.
Hospital Pharmacies accounted for XX% of the Opioid Use Disorder (OUD) market in 2023. Retail Pharmacies & Stores accounts for XX%.

This Opioid Use Disorder (OUD) market report provides detailed information on latest developments, trade regulations, value chain optimization, market share, impact of domestic and local market players, analyzes emerging revenue sources, market regulation changes Opportunities in Aspects, Strategic Market Growth Analysis, Market Size, Category Market Growth, Application Areas and Dominance, Product Approvals, Product Launches, Geographic Expansion, Technological Innovations in the Market.

Opioid Use Disorder (OUD) market country level analysis
The countries covered in the Opioid Use Disorder (OUD) market report include the United States, Canada, Germany, United Kingdom, France, Russia, Japan, China, India, South Korea, Brazil, UAE, Saudi Arabia, etc.
The presence and availability of global brands and challenges due to intense or scarce competition from local and domestic brands, and trade routes are also considered while providing the predictive analysis of country data.

Competitive Landscape and Opioid Use Disorder (OUD) Market Share Analysis
Opioid Use Disorder (OUD) market competitive landscape provides details by competitors. The detailed information includes company profile, company financials, revenue generated, market potential, R&D investments, new market plans, global reach. The data points presented above relate only to companies relevant to the Opioid Use Disorder (OUD) market.

Chapter Outline
Chapter 1: Introduces the product overview, market scope, product classification, and application division, and then includes research purposes, report timeline, and economic analysis of global regions.
Chapters 2-7: Provide Global, North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Opioid Use Disorder (OUD) market type, application, player and country market segmentation data.
Chapters 8-9: Segmented the global Opioid Use Disorder (OUD) market by type, and application. Analyze the revenue of market segments from different perspectives.
Chapter 10: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry, and includes industry mergers & acquisitions and industry new entrants and expansion plans.
Chapter 11: Analyzes the main companies in the Opioid Use Disorder (OUD) industry, including their main businesses, products/services, revenue, gross and gross margin.
Chapter 12: The main points and conclusions of the report.

Highlights-Regions

North America
United States
Canada
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
South America
Brazil
Argentina
Colombia
Mexico
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Player list
Indivior PLC (Reckitt Benckiser Group plc)
Collegium Pharmaceutical, Inc. (BioDelivery Sciences International, Inc.)
Orexo AB (Orexo US, Inc.)
Alkermes PLC
Titan Pharmaceuticals, Inc.
Camurus AB
AstraZeneca PLC
Hikma Pharmaceuticals PLC
Mallinckrodt PLC
Viatris, Inc.

Types list
Buprenorphine
Methadone
Naltrexone

Application list
Hospital Pharmacies
Retail Pharmacies & Stores
Online Pharmacies

Contact US Anytime

Contact US Anytime

Find More

Global Opioid Use Disorder (OUD) In-Depth Monitoring and Development Analysis Report 2024

Get a FREE sample

Have Requests? Need Customization? Our Research Team Will Help to Maximize Your "Interest Scope and Content Customization" into Our Analysis Report.

Custom Research
Dongguan Jianpeng Intelligent Technology Co., Ltd
top

Phone Number +86 195 30455980

Research Consulting reports@arstaresearch.com

Business Cooperation sales@arstaresearch.com

Copyright © 2020-2025 Arsta Research All Rights Reserved
Technical support : Cssl
Choose a different language
╳
English Español‎ Português Français Deutsch Русский Suomen Kieli Myanmar Tiếng Việt にほんご 한국어 Italiana हिन्दी Melayu ภาษาไทย اللغة العربية 中文(简体) 中文(繁体)

Sample Request

Message